The Leadership Team at MoonLake Immunotherapeutics provides strategic direction and oversight for the company's research, clinical development, technical operations, and financial management. This team ensures that the company's initiatives in developing innovative Nanobody® technology treatments for immunologic diseases are effectively executed, while also managing regulatory compliance, market access, and pricing strategies.
Andrew Fox
Vice President, Regulatory Aff...
Joana Ferreira Morei...
Vice President Clinical Develo...
Jorge Santos da Silv...
Founder & Chief Executive Offi...
Kristian Reich
Chief Scientific Officer
Matthias Bodenstedt
Chief Financial Officer
Nuala Brennan
Chief Clinical Development Off...
Oliver Daltrop
Chief Technical Officer
Prof. Dr. Kristian R...
Co-founder And Chief Scientifi...
Tino Anthamatten
VP Marketing, Market Access & ...
View all